The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia

Abstract Aims: Atopic dermatitis (AD) is a chronic skin disease that creates a significant burden to patients and society. There is scarcity in local data about the burden of AD in the Kingdom of Saudi Arabia (KSA). We aimed to fill in this gap and quantify the humanistic and economic burden of AD among adults and adolescents in KSA. Materials and methods: A literature search and local expert interviews were conducted to assess the disease burden. Prevalence values were estimated through the literature. International data about health-related quality of life lost owing to AD was adjusted to age and prevalence in KSA. Direct and indirect costs were calculated using a bottom-up approach. Resource utilization data were collected from local dermatologists through online interviews, and indirect costs were based on absenteeism and presenteeism estimates. Validation meetings were conducted with local experts to adjust the final estimates. Results: The age-standardized health loss per patient due to AD is 0.187 quality-adjusted life-years (QALYs) annually, aggregating to 64 thousand lost QALYs in KSA. The annual average direct cost for a patient with AD was 2924 Saudi Riyal (SAR; 780 USD), totaling 373 million SAR in KSA (99.5 million USD). This value represents 0.2% of the annual health expenditure in KSA. The total productivity loss due to AD was 1.36 billion SAR (363.7 million USD). Overall, the economic burden of AD consumes up to 0.059% of the national gross domestic product. Limitations: Local quality of life and productivity lost data were not available for KSA, so global averages were used, assuming these numbers also apply to KSA. Conclusion: Indirect costs represent a large proportion of AD burden in KSA. The disease has a substantial effect on patient quality of life and social well-being. Alleviating the burden might result in significant savings in resources to society. PLAIN LANGUAGE SUMMARY Atopic dermatitis is one of the most common skin diseases. Mild cases of the disease cause inflamed and itchy skin, while severe cases may cause painful episodes of itching and cracked skin. Patients with atopic dermatitis and their families suffer lower quality of life as the severity of the disease increases. In countries with hot weather like Saudi Arabia, skin is more susceptible to become dry, so the disease is very prevalent. Therefore, the disease poses a significant quality of life burden as well as an economic burden due to the direct costs of treatment and the indirect costs that arise because patients become non-productive or absent from work or school. Our study aimed to quantify the economic and quality of life burden of atopic dermatitis in Saudi Arabia to understand it’s real burden and help decision makers quantify its impact on the patients and society. We conducted a literature search and interviewed local experts to determine estimates of costs and quality of life effects. The results of this study should help in prioritizing treatment disease areas in Saudi Arabia and other countries with similar circumstances.

[1]  Z. Kaló,et al.  Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review , 2022, Dermatology and Therapy.

[2]  Z. Kaló,et al.  POSB168 The Burden of Atopic Dermatitis in Adults and Adolescents: A Systematic Literature Review , 2022, Value in Health.

[3]  A. Alghamdi,et al.  The Economic Burden Associated with the Management of Different Stages of Breast Cancer: A Retrospective Cost of Illness Analysis in Saudi Arabia , 2021, Healthcare.

[4]  J. Thyssen,et al.  Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect. , 2021, The journal of allergy and clinical immunology. In practice.

[5]  S. Chu,et al.  The global, regional, and national burden of atopic dermatitis in 195 countries and territories: An ecological study from the Global Burden of Disease Study 2017 , 2020, JAAD international.

[6]  F. Sampogna,et al.  Impact of Atopic Dermatitis in Adolescents and their Parents: A French Study , 2020, Acta dermato-venereologica.

[7]  R. Dellavalle,et al.  The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017 * , 2020, The British journal of dermatology.

[8]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[9]  Z. Kaló,et al.  Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status , 2020, Frontiers in Pharmacology.

[10]  H. Weess,et al.  Sleep Disturbance in Patients with Urticaria and Atopic Dermatitis: An Underestimated Burden , 2020, Acta dermato-venereologica.

[11]  J. Alqahtani Atopy and allergic diseases among Saudi young adults: A cross-sectional study , 2020, The Journal of international medical research.

[12]  M. Nyeland,et al.  Higher self‐reported severity of atopic dermatitis in adults is associated with poorer self‐reported health‐related quality of life in France, Germany, the U.K. and the U.S.A. , 2019, The British journal of dermatology.

[13]  R. Launois,et al.  Importance of out‐of‐pocket costs for adult patients with atopic dermatitis in France , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  G. de Carlo,et al.  Atopic eczema: burden of disease and individual suffering – results from a large EU study in adults , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  P. Le,et al.  Quality of life measurement alteration among Vietnamese: Impact and treatment benefit related to eczema. , 2019, JPMA. The Journal of the Pakistan Medical Association.

[16]  R. Gerber,et al.  Understanding the Burden of Atopic Dermatitis in Africa and the Middle East , 2019, Dermatology and Therapy.

[17]  G. de Carlo,et al.  Out-of-pocket Costs for Individuals with Atopic Eczema: A Cross-sectional Study in Nine European Countries. , 2019, Acta dermato-venereologica.

[18]  M. Ardeleanu,et al.  Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS‐J): Baseline characteristics, treatment history and disease burden , 2019, The Journal of dermatology.

[19]  P. Ibekwe,et al.  Impact of Weather Conditions on Atopic Dermatitis Prevalence in Abuja, Nigeria. , 2019, Journal of the National Medical Association.

[20]  Hussein M. Alshamrani,et al.  Pattern of skin diseases in a university hospital in Jeddah, Saudi Arabia: age and sex distribution , 2019, Annals of Saudi medicine.

[21]  K. Ezzedine,et al.  The impact of atopic dermatitis on sexual health , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[22]  M. Blaiss,et al.  The burden of atopic dermatitis. , 2018, Allergy and asthma proceedings.

[23]  G. Vilagut,et al.  Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries , 2018, The European Journal of Health Economics.

[24]  Si Hyung Lee,et al.  Psychological Health Status and Health-related Quality of Life in Adults with Atopic Dermatitis: A Nationwide Cross-sectional Study in South Korea. , 2018, Acta dermato-venereologica.

[25]  L. Eichenfield,et al.  The Disease Burden of Atopic Dermatitis. , 2017, Seminars in cutaneous medicine and surgery.

[26]  J. Silverberg,et al.  Relationship between EASI and SCORAD severity assessments for atopic dermatitis. , 2017, Journal of Allergy and Clinical Immunology.

[27]  J. Silverberg,et al.  Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis , 2017, The British journal of dermatology.

[28]  Jungsoo Lee,et al.  Clinical Diversity of Atopic Dermatitis: A Review of 5,000 Patients at a Single Institute , 2016, Allergy, asthma & immunology research.

[29]  Mai S. Labani,et al.  Prevalence and determinants of eczema among females aged 21 to 32 years in Jeddah city – Saudi Arabia , 2017 .

[30]  M. Tarbox,et al.  Atopic Dermatitis: Pathophysiology. , 2017, Advances in experimental medicine and biology.

[31]  J. Lyons,et al.  Atopic dermatitis in children: clinical features, pathophysiology, and treatment. , 2015, Immunology and allergy clinics of North America.

[32]  Simon Francis Thomsen,et al.  Atopic Dermatitis: Natural History, Diagnosis, and Treatment , 2014, ISRN allergy.

[33]  A. Alzolibani Impact of atopic dermatitis on the quality of life of Saudi children. , 2014, Saudi medical journal.

[34]  M. Augustin,et al.  Willingness to pay and quality of life in patients with atopic dermatitis , 2014, Archives of Dermatological Research.

[35]  Arshdeep Singh,et al.  Atopic dermatitis: an overview. , 2012, American family physician.

[36]  K. Alghamdi,et al.  Survey of dermatologists' phototherapy practices for vitiligo. , 2012, Indian journal of dermatology, venereology and leprology.

[37]  Rebecca J Mitchell,et al.  Measuring health-related productivity loss. , 2011, Population health management.

[38]  Paolo Lisi,et al.  Atopic Dermatitis in Adults , 2011, Dermatitis : contact, atopic, occupational, drug.

[39]  J. Carlin,et al.  Do boys do the atopic march while girls dawdle? , 2008, The Journal of allergy and clinical immunology.

[40]  Jon M Hanifin,et al.  A Population‐Based Survey of Eczema Prevalence in the United States , 2007, Dermatitis : contact, atopic, occupational, drug.

[41]  L. Buys,et al.  Treatment options for atopic dermatitis. , 2007, American family physician.

[42]  Rajesh Balkrishnan,et al.  The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society , 2005, Pediatric dermatology.

[43]  D. Fryback,et al.  HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health. , 2002, Annual review of public health.

[44]  H. Williams,et al.  Outcome measures of disease severity in atopic eczema. , 2000, Archives of dermatology.

[45]  S. Louis Bridges,et al.  National Institute of Arthritis and Musculoskeletal and Skin Diseases , 2000 .

[46]  A. Parthasaradhi,et al.  The pattern of skin diseases in Hail Region, Saudi Arabia. , 1998, Annals of Saudi medicine.

[47]  S. Umeki Allergic cycle: relationships between asthma, allergic rhinitis, and atopic dermatitis. , 1994, The Journal of asthma : official journal of the Association for the Care of Asthma.

[48]  G. Rajka Atopic Dermatitis , 1986, International journal of dermatology.

[49]  G. Beeson,et al.  in adults with , 2019 .